Document is current
Any future updates will be listed below
-
Authors
Mahaddalkar, Tejashree
Banerjee, Archisman https://orcid.org/0000-0002-1499-8612
Ketkar, Madhura https://orcid.org/0000-0003-4412-5086
Thorat, Rahul
Gardi, Nilesh
Dutt, Shilpee https://orcid.org/0000-0003-4217-5127
-
Funding
Funding for this research was provided by:
Department of Science and Technology, Ministry of Science and Technology (EMR/2017/004994)
Department of Atomic Energy, Government of India (1/3(7)/2020/TMC/R&D-II/8823, 1/3(6)/2020/TMC/R&D-II/3805)
- License Information
-
More Information
Article History
Received: 10 July 2024
Revised: 28 February 2025
Accepted: 25 March 2025
First Online: 7 April 2025
Competing interests
: The authors declare no competing interests.
: Fresh naïve GBM patient tumor samples were obtained during surgery after approval from the Tata Memorial Centre Institutional Ethics Committee (TMC-IEC III) (DCGI Reg. No.: IEC III:- ECR/149/Inst/MH/2013/RR-24) (TMC project number 77) with a written consent form in a language understood by the patients. All animal experiments were licensed through the Laboratory Animal Facility at ACTREC, TMC (project number 33/2023). All animal experiments followed Institutional Animal Ethics committee, ACTREC approved protocols. All methods were performed in accordance with the relevant guidelines and regulations.
